Recent publications
Article
Zannat, R, Lee, J, Muzaffar, J, Read, M, Brookes, K, Sharma, N, Boelaert, K, McCabe, C & Nieto, H 2023, 'The potential interaction between medical treatment and radioiodine treatment success: A systematic review.', Frontiers in Endocrinology, vol. 13, 1061555. https://doi.org/10.3389/fendo.2022.1061555
Nieto, H, Thornton, C, Brookes, K, Nobre De Menezes, A, Fletcher, A, Alshahrani, M, Kocbiyik, M, Sharma, N, Boelaert, K, Cazier, J-B, Mehanna, H, Smith, V, Read, M & McCabe, C 2021, 'Recurrence of papillary thyroid cancer: a systematic appraisal of risk factors', Journal of Clinical Endocrinology and Metabolism, vol. 107, no. 5, pp. 1392–1406. https://doi.org/10.1210/clinem/dgab836
Abstract
Brookes, K, Zha, L, Kim, J, Kannappan, V, Wang, W, Sunassee, K, Blower, P, Smith, V, Read, M & McCabe, C 2023, 'A critical role for copper in enhanced radioiodide uptake in thyroid cancer cells', Cancer Research, vol. 83, no. 7_Supplement, 5053. https://doi.org/10.1158/1538-7445.AM2023-5053
Brookes, K, Zha, L, Kim, J, Small, B, Kocbiyik, M, Manivannan, S, Kannappan, V, Wang, W, Sunassee, K, Blower, P, Nieto, H, Smith, V, Read, M & McCabe, C 2023, 'Copper-based therapeutics increase sodium/iodide symporter (NIS) transcription and enhance radioiodide uptake in thyroid cancer cells', Endocrine Abstracts, vol. 90, OC11.1. https://doi.org/10.1530/endoabs.90.OC11.1
Read, M, Brookes, K, Zha, L, Thornton, C, Kim, J, Fletcher, A, Firth, G, Sunassee, K, Blower, P, Nieto, H, Smith, V & McCabe, C 2022, 'Dissecting endocytic mechanisms reveals new molecular targets to enhance sodium iodide symporter activity with clinical relevance to radioiodide therapy', Thyroid, vol. 32, no. S1, OC29, pp. A92-A92. https://doi.org/10.1089/thy.2022.29137.abstracts
Zha, L, Brookes, K, Thornton, C, Fletcher, A, Kim, J, Sunassee, K, Blower, P, Nieto, H, Smith, V, Read, M & McCabe, C 2022, 'Enhancing radioiodide uptake by addressing the mechanism of sodium/iodide symporter (NIS) endocytosis', Endocrine Abstracts, vol. 86, OC6.2. https://doi.org/10.1530/endoabs.86.OC6.2
Manivannan, S, Alshahrani, M, Thornton, C, Raja, S, Kocbiyik, M, Zha, L, Brookes, K, Nieto, H, Read, M, McCabe, C & Smith, V 2022, 'Promotion of thyroid cancer cell migration and invasion by the proto-oncogene PBF is mediated by FGD1 and N-WASP', Thyroid, vol. 32, no. S1, OC27, pp. A91-A91. https://doi.org/10.1089/thy.2022.29137.abstracts
Read, M, Brookes, K, Zha, L, Moolla, M, Kocbiyik, M, Manivannan, S, Hoare, R, Kannappan, V, Wang, W, Sunassee, K, Blower, P, Nieto, H, Smith, V & McCabe, C 2022, 'Repurposing disulfiram as a therapeutic agent to enhance sodium iodide symporter activity in radioiodide therapy', Endocrine Abstracts, vol. 86, OC2.6. https://doi.org/10.1530/endoabs.86.OC2.6
Brookes, K, Zha, L, Moolla, M, Kim, J, Kocbiyik, M, Manivannan, S, Nieto, H, Kannappan, V, Wang, W, Sunassee, K, Blower, P, Smith, V, Read, M & McCabe, C 2022, 'Repurposing of disulfiram and diethyldithiocarbamate (DDC)-metal complexes to enhance sodium iodide symporter function in radioiodide therapy', Thyroid, vol. 32, no. S1, OC40, pp. A96-A97. https://doi.org/10.1089/thy.2022.29137.abstracts
Thornton, C, Brookes, K, Fletcher, A, Nieto, H, Zha, L, Kocbiyik, M, Read, M, Smith, V & McCabe, C 2021, 'AP-2 and moesin regulate the internalisation of the sodium-iodide symporter and affect I125 Uptake in thyroid cancer cells', Endocrine Abstracts, vol. 77, OC6.4. https://doi.org/10.1530/endoabs.77.OC6.4
Read, M, Brookes, K, Thornton, C, Nieto, H, Fletcher, A, Borges de Souza, P, Alshahrani, M, Zha, L, Webster, J, Alderwick, L, Boelaert, K, Smith, V & McCabe, C 2021, 'Abstract PO-006: Exploiting non-canonical pathways of NIS regulation to enhance radioiodide uptake and identify predictive markers of recurrence in thyroid cancer', Clinical Cancer Research, vol. 27, no. 8 Supplement, PO-006. https://doi.org/10.1158/1557-3265.RADSCI21-PO-006
Read, M, Brookes, K, Thornton, C, Nieto, H, Zha, L, Fletcher, A, Boelaert, K, Smith, V & McCabe, C 2021, 'An emerging role for proteostasis modulators targeting NIS activity to enhance radioiodide therapy in thyroid cancer', Endocrine Abstracts, vol. 77, OC2.2. https://doi.org/10.1530/endoabs.77.OC2.2
Read, M, Brookes, K, Thornton, C, Nieto, H, Fletcher, A, Zha, L, Alderwick, L, Boelaert, K, Smith, V & McCabe, C 2021, 'Exploiting non-canonical pathways of NIS regulation to enhance radioiodide uptake and identify predictive markers of thyroid cancer recurrence', Nuclear Medicine Communications, vol. 42, no. 5. https://doi.org/10.1097/MNM.0000000000001180
Kocbiyik, M, Alshahrani, M, Poole, V, Jeyanathan, S, Thornton, C, Zha, L, Brookes, K, Nieto, H, Read, M, McCabe, C & Smith, V 2021, 'PBF phosphorylation regulates cell motility of thyroid and breast cancer cells', Endocrine Abstracts, vol. 77, OC2.4. https://doi.org/10.1530/endoabs.77.OC2.4
Preprint
Read, M, Brookes, K, Zha, L, Manivannan, S, Kim, J, Kocbiyik, M, Fletcher, A, Gorvin, CM, Firth, G, Fruhwirth, G, Nicola, J, Jhiang, S, Ringel, M, Campbell, M, Sunassee, K, Blower, P, Boelaert, K, Nieto, H, Smith, V & McCabe, C 2023 'Dissecting endocytic mechanisms reveals new molecular targets to enhance sodium iodide symporter activity with clinical relevance to radioiodide therapy' bioRxiv. https://doi.org/10.1101/2023.05.22.541733
View all publications in research portal